Bitolterol mesylate, inhalation solution, compounded product, administered through dme, concentrated form, per milligram
Code effective Jan 01, 2007
HCPCS Section
Drugs administered other than oral method, chemotherapy drugs
J7628 is a valid 2026 HCPCS code meaning Bitolterol mesylate, inhalation solution, compounded product, administered through dme, concentrated form, per milligram or (Bitolterol mesylate comp con) for short. HCPCS J7628 has been effective since 01/01/2007 and applies to Medical care.
|
HCPCS Level II Code Section J - Drugs administered other than oral method, chemotherapy drugs |
|
| HCPCS Code | J7628 |
|---|---|
| Description |
Long description:
Short description: |
| HCPCS Pricing indicator |
51 - Drugs
|
| Multiple pricing indicator |
A - Not applicable as HCPCS priced under one methodology
|
| Coverage code | D - Special coverage instructions apply |
| BETOS2 code | D1G - Drugs Administered through DME |
| HCPCS Action code | N - No maintenance for this code |
| Type of service | 1 - Medical care |
| Effective date | Effective Jan 01, 2007 |
| Date added | Added Jan 01, 2000 |
1 Two-digit numeric codes are Level I code modifiers copyrighted© by the American Medical Association's Current Procedural Terminology (CPT).
2 BETOS stands for “Berenson-Eggers Type Of Service”
HCPCS Level II codes and descriptors are approved and maintained jointly by the alpha-numeric editorial panel (consisting of CMS, the Health Insurance Association of America, and the Blue Cross and Blue Shield Association). — Updated 6/23/2026
CPT® is a registered trademark of the American Medical Association (AMA). All rights reserved.